SPE2D219D0075P00003 signed.pdf

This document provides details on a forthcoming solicitation from the Defense Logistics Agency for a requirements contract for Budesonide Inhalation Suspension. The contract will have a one year base period and four one year options. The solicitation is expected to be issued in August 2018 and will establish a national supply source for Budesonide Inhalation Suspension in 1MG/2ML, 0.25MG/2ML, and 0.5MG/2ML packaging to customers of the Defense Logistics Agency, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs through their prime vendor programs. The contract will be firm-fixed price and annual usage estimates will be provided in the solicitation. Interested parties are advised to contact the point of contact for any questions and to set up automated notifications for changes to the pre-solicitation or solicitation.